IV-SC Bridging: How Can MIDD Help

Recorded On: 10/23/2024

You must log in to register
- Member - Free!
Continue

Overview of the 2024 MIDD Webinar Series

The 2024 MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.

Anne Gaelle Dosne

Pharmacometrician

Argenx

Anne-Gaëlle is currently working as director of CPP at argenx, a Belgium-based biotech company specialized in immunology innovation for rare diseases, after spending 8 years within Janssen’s (J&J Innovative Medecine) CPP group. Her experience in IV-SC bridging arises both through project work and through a multidisciplinary collaboration with health authorities and other pharmaceutical industries during the ACoP pre-conference workshop in 2022, which resulted in an article on the topic.

Anne-Gaëlle is a pharmacist by training and obtained her PharmD at Paris Descartes University (France) in 2011. She completed her PhD program at Uppsala University (Sweden) in 2015 in collaboration with Novartis. She is passionate about applying quantitative pharmacology principles at different stages of drug development across therapeutic areas and modalities